ImCare Biotech has been awarded SBIR grant by NCI (NIH) (National Cancer Institute) to develop its diagonistic kit Seravue® for early detection of liver cancer (HCC and ICC) on 9/2012.
USA patent Number US8193328B2: Identification of modulators of serine protease inhibitor Kazal (SPIK) and their use as anti-cancer and anti-viral agent (Inventor Xuanyong Lu and T. Block) has been published on 6/5/2012. This patent protects ImCare Biotech to study and develop their products.
ImCare biotech has signed agreement with Drexel University, College of Medicine and University of California, Irvine, Medical Center to develop Seravue®.
COMPANY EVENTS PRODUCTS
